BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Arai K, Teratani T, Kuruto-niwa R, Yamada T, Nozawa R. S100A9 expression in invasive ductal carcinoma of the breast. European Journal of Cancer 2004;40:1179-87. [DOI: 10.1016/j.ejca.2004.01.022] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 2.9] [Reference Citation Analysis]
Number Citing Articles
1 Ni Bhriain H, Trovik J, Wik E, Stefansson IM, Akslen LA, Salvesen HB, Staff AC. Plasma calprotectin concentrations in women with endometrial carcinoma. Gynecologic Oncology 2009;114:491-5. [DOI: 10.1016/j.ygyno.2009.06.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
2 Wang T, Huo X, Chong Z, Khan H, Liu R, Wang T. A review of S100 protein family in lung cancer. Clin Chim Acta 2018;476:54-9. [PMID: 29146477 DOI: 10.1016/j.cca.2017.11.010] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 4.8] [Reference Citation Analysis]
3 Li MX, Xiao ZQ, Liu YF, Chen YH, Li C, Zhang PF, Li MY, Li F, Peng F, Duan CJ, Yi H, Yao HX, Chen ZC. Quantitative proteomic analysis of differential proteins in the stroma of nasopharyngeal carcinoma and normal nasopharyngeal epithelial tissue. J Cell Biochem 2009;106:570-9. [PMID: 19142861 DOI: 10.1002/jcb.22028] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
4 Imaoka T, Yamashita S, Nishimura M, Kakinuma S, Ushijima T, Shimada Y. Gene expression profiling distinguishes between spontaneous and radiation-induced rat mammary carcinomas. J Radiat Res 2008;49:349-60. [PMID: 18421211 DOI: 10.1269/jrr.07126] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
5 Fan B, Zhang LH, Jia YN, Zhong XY, Liu YQ, Cheng XJ, Wang XH, Xing XF, Hu Y, Li YA. Presence of S100A9-positive inflammatory cells in cancer tissues correlates with an early stage cancer and a better prognosis in patients with gastric cancer. BMC Cancer. 2012;12:316. [PMID: 22838504 DOI: 10.1186/1471-2407-12-316] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
6 Kayabasi S, Kuzucu I. A novel prognostic biomarker for recurrent aphthous stomatitis: calprotectin. J Laryngol Otol 2019;133:691-5. [PMID: 31284886 DOI: 10.1017/S0022215119001440] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Chan MM, Lu X, Merchant FM, Dirk Iglehart J, Miron PL. Serial transplantation of NMU-induced rat mammary tumors: A model of human breast cancer progression. Int J Cancer 2007;121:474-85. [DOI: 10.1002/ijc.22684] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
8 Ito Y, Arai K, Ryushi, Nozawa, Yoshida H, Tomoda C, Uruno T, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Kakudo K, Miyauchi A. S100A9 expression is significantly linked to dedifferentiation of thyroid carcinoma. Pathology - Research and Practice 2005;201:551-6. [DOI: 10.1016/j.prp.2005.08.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
9 Koh HM, An HJ, Ko GH, Lee JH, Lee JS, Kim DC, Yang JW, Kim MH, Kim SH, Jeon KN, Lee GW, Jang SM, Song DH. Prognostic Role of S100A8 and S100A9 Protein Expressions in Non-small Cell Carcinoma of the Lung. J Pathol Transl Med 2019;53:13-22. [PMID: 30472816 DOI: 10.4132/jptm.2018.11.12] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Kim K, Kim KH, Roh K, Yoo BC, Ku JL, Shin YK, Cho JY, Kim M, Kwon MH, Goh SH, Chang HJ, Oh JH. Antitumor effects of calgranulin B internalized in human colon cancer cells. Oncotarget 2016;7:20368-80. [PMID: 26933915 DOI: 10.18632/oncotarget.7783] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
11 Qin F, Song Y, Li Z, Zhao L, Zhang Y, Geng L. S100A8/A9 induces apoptosis and inhibits metastasis of CasKi human cervical cancer cells. Pathol Oncol Res. 2010;16:353-360. [PMID: 19957061 DOI: 10.1007/s12253-009-9225-2] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 2.5] [Reference Citation Analysis]
12 Markowitz J, Carson WE. Review of S100A9 biology and its role in cancer. Biochim Biophys Acta. 2013;1835:100-109. [PMID: 23123827 DOI: 10.1016/j.bbcan.2012.10.003] [Cited by in Crossref: 32] [Cited by in F6Publishing: 71] [Article Influence: 3.2] [Reference Citation Analysis]
13 Xu Y, Cao LQ, Jin LY, Chen ZC, Zeng GQ, Tang CE, Li GQ, Duan CJ, Peng F, Xiao ZQ, Li C. Quantitative proteomic study of human lung squamous carcinoma and normal bronchial epithelial acquired by laser capture microdissection. J Biomed Biotechnol 2012;2012:510418. [PMID: 22500095 DOI: 10.1155/2012/510418] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
14 Kostakis ID, Cholidou KG, Kallianidis K, Perrea D, Antsaklis A. The role of calprotectin in obstetrics and gynecology. Eur J Obstet Gynecol Reprod Biol 2010;151:3-9. [PMID: 20378239 DOI: 10.1016/j.ejogrb.2010.03.006] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
15 Topuz MF, Binnetoglu A, Yumusakhuylu AC, Sarı M, Baglam T, Gerin F. Circulating calprotectin as a biomarker of laryngeal carcinoma. Eur Arch Otorhinolaryngol 2017;274:2499-504. [PMID: 28251322 DOI: 10.1007/s00405-017-4480-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
16 Choo JR, Nielsen TO. Biomarkers for Basal-like Breast Cancer. Cancers (Basel) 2010;2:1040-65. [PMID: 24281106 DOI: 10.3390/cancers2021040] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
17 Bergenfelz C, Gaber A, Allaoui R, Mehmeti M, Jirström K, Leanderson T, Leandersson K. S100A9 expressed in ER(-)PgR(-) breast cancers induces inflammatory cytokines and is associated with an impaired overall survival. Br J Cancer 2015;113:1234-43. [PMID: 26448179 DOI: 10.1038/bjc.2015.346] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
18 Nofech-mozes S, Spayne J, Rakovitch E, Kahn HJ, Seth A, Pignol J, Lickley L, Paszat L, Hanna W. Biological Markers Predictive of Invasive Recurrence in DCIS. Clinical medicine Oncology 2008;2:117955490800200. [DOI: 10.1177/117955490800200202] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
19 Gebhardt C, Németh J, Angel P, Hess J. S100A8 and S100A9 in inflammation and cancer. Biochem Pharmacol 2006;72:1622-31. [PMID: 16846592 DOI: 10.1016/j.bcp.2006.05.017] [Cited by in Crossref: 453] [Cited by in F6Publishing: 433] [Article Influence: 28.3] [Reference Citation Analysis]
20 Ødegaard E, Davidson B, Elgaaen BV, Fagerhol MK, Engh V, Onsrud M, Staff AC. Circulating calprotectin in ovarian carcinomas and borderline tumors of the ovary. American Journal of Obstetrics and Gynecology 2008;198:418.e1-7. [DOI: 10.1016/j.ajog.2007.10.792] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
21 Zhao L, Wang H, Sun X, Ding Y. Comparative proteomic analysis identifies proteins associated with the development and progression of colorectal carcinoma: Proteins with the genesis and progression of CRC. FEBS Journal 2010;277:4195-204. [DOI: 10.1111/j.1742-4658.2010.07808.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
22 Zhao Z, Zhang C, Zhao Q. S100A9 as a novel diagnostic and prognostic biomarker in human gastric cancer. Scand J Gastroenterol 2020;55:338-46. [PMID: 32172630 DOI: 10.1080/00365521.2020.1737883] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
23 Li C, Chen H, Ding F, Zhang Y, Luo A, Wang M, Liu Z. A novel p53 target gene, S100A9, induces p53-dependent cellular apoptosis and mediates the p53 apoptosis pathway. Biochem J 2009;422:363-72. [PMID: 19534726 DOI: 10.1042/BJ20090465] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
24 Ghavami S, Chitayat S, Hashemi M, Eshraghi M, Chazin WJ, Halayko AJ, Kerkhoff C. S100A8/A9: a Janus-faced molecule in cancer therapy and tumorgenesis. Eur J Pharmacol 2009;625:73-83. [PMID: 19835859 DOI: 10.1016/j.ejphar.2009.08.044] [Cited by in Crossref: 72] [Cited by in F6Publishing: 72] [Article Influence: 5.5] [Reference Citation Analysis]
25 Ghavami S, Rashedi I, Dattilo BM, Eshraghi M, Chazin WJ, Hashemi M, Wesselborg S, Kerkhoff C, Los M. S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway. J Leukoc Biol. 2008;83:1484-1492. [PMID: 18339893 DOI: 10.1189/jlb.0607397] [Cited by in Crossref: 197] [Cited by in F6Publishing: 207] [Article Influence: 14.1] [Reference Citation Analysis]
26 Nofech-Mozes S, Spayne J, Rakovitch E, Hanna W. Prognostic and predictive molecular markers in DCIS: a review. Adv Anat Pathol 2005;12:256-64. [PMID: 16210921 DOI: 10.1097/01.pap.0000184177.65919.5e] [Cited by in Crossref: 56] [Cited by in F6Publishing: 47] [Article Influence: 3.3] [Reference Citation Analysis]
27 Hawthorn L, Stein L, Panzarella J, Loewen GM, Baumann H. Characterization of cell-type specific profiles in tissues and isolated cells from squamous cell carcinomas of the lung. Lung Cancer 2006;53:129-42. [PMID: 16757060 DOI: 10.1016/j.lungcan.2006.04.015] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 2.3] [Reference Citation Analysis]
28 Man YG, Sang QX. The significance of focal myoepithelial cell layer disruptions in human breast tumor invasion: a paradigm shift from the "protease-centered" hypothesis. Exp Cell Res 2004;301:103-18. [PMID: 15530847 DOI: 10.1016/j.yexcr.2004.08.037] [Cited by in Crossref: 56] [Cited by in F6Publishing: 66] [Article Influence: 3.3] [Reference Citation Analysis]
29 Grote J, König S, Ackermann D, Sopalla C, Benedyk M, Los M, Kerkhoff C. Identification of poly(ADP-ribose)polymerase-1 and Ku70/Ku80 as transcriptional regulators of S100A9 gene expression. BMC Mol Biol 2006;7:48. [PMID: 17187679 DOI: 10.1186/1471-2199-7-48] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
30 Wiechmann L, Kuerer HM. The molecular journey from ductal carcinoma in situ to invasive breast cancer. Cancer 2008;112:2130-42. [DOI: 10.1002/cncr.23430] [Cited by in Crossref: 89] [Cited by in F6Publishing: 81] [Article Influence: 6.4] [Reference Citation Analysis]
31 Bode G, Lüken A, Kerkhoff C, Roth J, Ludwig S, Nacken W. Interaction between S100A8/A9 and Annexin A6 Is Involved in the Calcium-induced Cell Surface Exposition of S100A8/A9. Journal of Biological Chemistry 2008;283:31776-84. [DOI: 10.1074/jbc.m803908200] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
32 Jiang Z, Gui S, Zhang Y. Analysis of differential gene expression by fiber-optic BeadArray and pathway in prolactinomas. Endocr 2010;38:360-8. [DOI: 10.1007/s12020-010-9389-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
33 Sheikh AA, Vimalachandran D, Thompson CC, Jenkins RE, Nedjadi T, Shekouh A, Campbell F, Dodson A, Prime W, Crnogorac-Jurcevic T. The expression of S100A8 in pancreatic cancer-associated monocytes is associated with the Smad4 status of pancreatic cancer cells. Proteomics. 2007;7:1929-1940. [PMID: 17469085 DOI: 10.1002/pmic.200700072] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 2.8] [Reference Citation Analysis]
34 Zhu X, Lv J, Yu L, Zhu X, Wu J, Zou S, Jiang S. Proteomic identification of differentially-expressed proteins in squamous cervical cancer. Gynecologic Oncology 2009;112:248-56. [DOI: 10.1016/j.ygyno.2008.09.045] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 2.8] [Reference Citation Analysis]
35 Celis JE, Moreira JM, Gromova I, Cabezón T, Gromov P, Shen T, Timmermans V, Rank F. Characterization of breast precancerous lesions and myoepithelial hyperplasia in sclerosing adenosis with apocrine metaplasia. Mol Oncol 2007;1:97-119. [PMID: 19383289 DOI: 10.1016/j.molonc.2007.02.005] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
36 Gunaldi M, Okuturlar Y, Gedikbasi A, Akarsu C, Karabulut M, Kural A. Diagnostic importance of S100A9 and S100A12 in breast cancer. Biomed Pharmacother 2015;76:52-6. [PMID: 26653550 DOI: 10.1016/j.biopha.2015.10.029] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
37 Huang A, Cao S, Tang L. The tumor microenvironment and inflammatory breast cancer. J Cancer 2017;8:1884-91. [PMID: 28819386 DOI: 10.7150/jca.17595] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
38 Zheng H, Jiang WH, Tian T, Tan HS, Chen Y, Qiao GL, Han J, Huang SY, Yang Y, Li S, Wang ZG, Gao R, Ren H, Xing H, Ni JS, Wang LH, Ma LJ, Zhou WP. CBX6 overexpression contributes to tumor progression and is predictive of a poor prognosis in hepatocellular carcinoma. Oncotarget 2017;8:18872-84. [PMID: 28122351 DOI: 10.18632/oncotarget.14770] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
39 Raymond E, Dalgleish A, Damber JE, Smith M, Pili R. Mechanisms of action of tasquinimod on the tumour microenvironment. Cancer Chemother Pharmacol. 2014;73:1-8. [PMID: 24162378 DOI: 10.1007/s00280-013-2321-8] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 4.9] [Reference Citation Analysis]
40 Domoto T, Miyama Y, Suzuki H, Teratani T, Arai K, Sugiyama T, Takayama T, Mugiya S, Ozono S, Nozawa R. Evaluation of S100A10, annexin II and B-FABP expression as markers for renal cell carcinoma. Cancer Sci. 2007;98:77-82. [PMID: 17083565 DOI: 10.1111/j.1349-7006.2006.00355.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 3.4] [Reference Citation Analysis]
41 Zhu H, Pei HP, Zeng S, Chen J, Shen LF, Zhong MZ, Yao RJ, Shen H. Profiling protein markers associated with the sensitivity to concurrent chemoradiotherapy in human cervical carcinoma. J Proteome Res 2009;8:3969-76. [PMID: 19507834 DOI: 10.1021/pr900287a] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
42 Celis JE, Gromova I, Cabezón T, Gromov P, Shen T, Timmermans-Wielenga V, Rank F, Moreira JM. Identification of a subset of breast carcinomas characterized by expression of cytokeratin 15: relationship between CK15+ progenitor/amplified cells and pre-malignant lesions and invasive disease. Mol Oncol 2007;1:321-49. [PMID: 19383306 DOI: 10.1016/j.molonc.2007.09.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
43 Reeb AN, Li W, Sewell W, Marlow LA, Tun HW, Smallridge RC, Copland JA, Spradling K, Chernock R, Lin RY. S100A8 is a novel therapeutic target for anaplastic thyroid carcinoma. J Clin Endocrinol Metab 2015;100:E232-42. [PMID: 25423568 DOI: 10.1210/jc.2014-2988] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
44 Ito Y, Miyauchi A, Arai K, Nozawa R, Miya A, Kobayashi K, Nakamura Y, Kakudo K. Usefulness of S100A9 for diagnosis of intrathyroid epithelial thymoma (ITET)/carcinoma showing thymus-like differentiation (CASTLE). Pathology 2006;38:541-4. [PMID: 17393982 DOI: 10.1080/00313020601024086] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
45 Fang Q, Yao S, Luo G, Zhang X. Identification of differentially expressed genes in human breast cancer cells induced by 4-hydroxyltamoxifen and elucidation of their pathophysiological relevance and mechanisms. Oncotarget 2018;9:2475-501. [PMID: 29416786 DOI: 10.18632/oncotarget.23504] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
46 Yong H, Moon A. Roles of calcium-binding proteins, S100A8 and S100A9, in invasive phenotype of human gastric cancer cells. Arch Pharm Res 2007;30:75-81. [DOI: 10.1007/bf02977781] [Cited by in Crossref: 54] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
47 Mou Z, Zhou J, Li J, Zou L, Zhou W, Wu Y. Expression of small hairpin RNAs for S100A9 used in the protein function research. Leuk Res 2006;30:1013-7. [PMID: 16417921 DOI: 10.1016/j.leukres.2005.11.009] [Reference Citation Analysis]
48 Zhao J, Chang AC, Li C, Shedden KA, Thomas DG, Misek DE, Manoharan AP, Giordano TJ, Beer DG, Lubman DM. Comparative proteomics analysis of Barrett metaplasia and esophageal adenocarcinoma using two-dimensional liquid mass mapping. Mol Cell Proteomics 2007;6:987-99. [PMID: 16829691 DOI: 10.1074/mcp.M600175-MCP200] [Cited by in Crossref: 30] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
49 Zhu X, Jin L, Zou S, Shen Q, Jiang W, Lin W, Zhu X. Immunohistochemical expression of RAGE and its ligand (S100A9) in cervical lesions. Cell Biochem Biophys 2013;66:843-50. [PMID: 23340902 DOI: 10.1007/s12013-013-9515-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
50 Tabur S, Korkmaz H, Özkaya M, Elboğa U, Tarakçıoglu M, Aksoy N, Akarsu E. Serum calprotectin: a new potential biomarker for thyroid papillary carcinoma. Tumour Biol 2015;36:7549-56. [PMID: 25916207 DOI: 10.1007/s13277-015-3468-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
51 Arai K, Iwasaki T, Sonoda A, Endo A. Membranous overexpression of S100A10 is associated with a high-grade cellular status of breast carcinoma. Med Mol Morphol 2020;53:104-14. [PMID: 31728728 DOI: 10.1007/s00795-019-00236-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
52 Salama I, Malone PS, Mihaimeed F, Jones JL. A review of the S100 proteins in cancer. Eur J Surg Oncol. 2008;34:357-364. [PMID: 17566693 DOI: 10.1016/j.ejso.2007.04.009] [Cited by in Crossref: 299] [Cited by in F6Publishing: 297] [Article Influence: 19.9] [Reference Citation Analysis]